LOW GRADE SEROUS OVARIAN CANCER
Clinical trials for LOW GRADE SEROUS OVARIAN CANCER explained in plain language.
Never miss a new study
Get alerted when new LOW GRADE SEROUS OVARIAN CANCER trials appear
Sign up with your email to follow new studies for LOW GRADE SEROUS OVARIAN CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo shows promise in Hard-to-Treat cancers
Disease control OngoingThis early-phase trial tests two experimental drugs, defactinib and VS-6766, together in people with advanced solid tumors that have stopped responding to standard treatments. The study includes patients with certain lung, ovarian, endometrial, and pancreatic cancers. The main go…
Matched conditions: LOW GRADE SEROUS OVARIAN CANCER
Phase: PHASE1 • Sponsor: Institute of Cancer Research, United Kingdom • Aim: Disease control
Last updated Jun 15, 2026 19:08 UTC
-
New hope for rare ovarian cancer: drug combo tested in japanese patients
Disease control OngoingThis study tests two drugs, avutometinib and defactinib, in 16 Japanese patients whose low-grade serous ovarian cancer has come back after platinum-based chemotherapy. The goal is to see if the combination can shrink tumors and control the disease. Participants must have measurab…
Matched conditions: LOW GRADE SEROUS OVARIAN CANCER
Phase: PHASE2 • Sponsor: Verastem, Inc. • Aim: Disease control
Last updated Jun 15, 2026 18:56 UTC